{"disease":{"id":"cryptosporidiosis","name":"cryptosporidiosis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04332705","title":"Cryptosporidium Infection and Human Colorectal Cancer","phase":"","overall_status":"UNKNOWN","enrollment_count":324,"lead_sponsor_name":"Lille Catholic University","has_results":false},{"nct_id":"NCT00001162","title":"Parasitic Infections of the Gastrointestinal Tract","phase":"","overall_status":"TERMINATED","enrollment_count":150,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT07249463","title":"Study Testing the Efficacy, Safety, and Tolerability of EDI048 in Cryptosporidium Infection Model in Healthy Adults","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT04103216","title":"Treatment of Cryptosporidiosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":64,"lead_sponsor_name":"International Centre for Diarrhoeal Disease Research, Bangladesh","has_results":false},{"nct_id":"NCT03341767","title":"A Phase 2A Evaluation of the Safety, Tolerability, Pharmacokinetics, Efficacy of Clofazimine (CFZ) in Cryptosporidiosis","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":33,"lead_sponsor_name":"University of Washington","has_results":false},{"nct_id":"NCT05036668","title":"Study of Efficacy and Safety of ABO809 in Healthy Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}